Previous Article | Next Article 
Molecular and Cellular Biology, October 1998, p. 5838-5851, Vol. 18, No. 10
0270-7306/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
Identification of a Novel Cortactin SH3 Domain-Binding Protein
and Its Localization to Growth Cones of Cultured Neurons
Yunrui
Du,
Scott A.
Weed,
Wen-Cheng
Xiong,
Trudy D.
Marshall,
and
J. Thomas
Parsons*
Department of Microbiology and Cancer Center,
University of Virginia Health Science Center, Charlottesville,
Virginia 22908
Received 23 April 1998/Returned for modification 21 May
1998/Accepted 18 June 1998
 |
ABSTRACT |
Cortactin is an actin-binding protein that contains several
potential signaling motifs including a Src homology 3 (SH3) domain at
the distal C terminus. Translocation of cortactin to specific cortical
actin structures and hyperphosphorylation of cortactin on tyrosine have
been associated with the cortical cytoskeleton reorganization induced
by a variety of cellular stimuli. The function of cortactin in these
processes is largely unknown in part due to the lack of information
about cellular binding partners for cortactin. Here we report the
identification of a novel cortactin-binding protein of approximately
180 kDa by yeast two-hybrid interaction screening. The interaction of
cortactin with this 180-kDa protein was confirmed by both in vitro and
in vivo methods, and the SH3 domain of cortactin was found to direct
this interaction. Since this protein represents the first reported
natural ligand for the cortactin SH3 domain, we designated it CortBP1
for cortactin-binding protein 1. CortBP1 contains two recognizable
sequence motifs within its C-terminal region, including a consensus
sequence for cortactin SH3 domain-binding peptides and a sterile alpha
motif. Northern and Western blot analysis indicated that CortBP1 is
expressed predominately in brain tissue. Immunofluorescence studies
revealed colocalization of CortBP1 with cortactin and cortical actin
filaments in lamellipodia and membrane ruffles in fibroblasts
expressing CortBP1. Colocalization of endogenous CortBP1 and cortactin
was also observed in growth cones of developing hippocampal neurons, implicating CortBP1 and cortactin in cytoskeleton reorganization during
neurite outgrowth.
 |
INTRODUCTION |
Cells undergo rearrangement of the
cortical cytoskeleton, a submembranous actin filament (F-actin)-based
network, during a variety of cellular processes including
differentiation, proliferation, migration, and oncogenic transformation
(9, 10, 43, 67). The cortical cytoskeleton not only controls
cell morphology but is also involved in transmitting signals between
the plasma membrane and intracellular compartments (7, 8,
38). A large body of evidence indicates that small GTP-binding
proteins, tyrosine kinases, and serine/threonine kinases play a pivotal
role in regulating the dynamic structure of the cortical cytoskeleton
(30, 33). The molecular mechanisms by which these enzymes
regulate cortical actin polymerization and reorganization are currently
unclear. Identification of actin-associated targets of these enzymes is important for unveiling signaling pathways correlated with the cortical F-actin remodeling.
Cortactin, an F-actin-binding substrate for the nonreceptor tyrosine
kinase pp60src (39, 78), is
distinguished by the presence of several potential signaling sequence
motifs (63, 77, 79). The N-terminal half of the protein
contains six and a half tandem repeats of a 37-amino-acid sequence. The
repeat region is required and sufficient for efficient association with
F-actin as assessed by in vitro cosedimentation assays (78).
The role of this region in mediating the interaction with F-actin has
been further confirmed by the blockage of the cosedimentation of
cortactin with F-actin by a cortactin-specific monoclonal antibody
(MAb) whose epitope is located in the repeats (78). Since
this region does not show significant sequence similarities with other
actin-binding proteins, cortactin represents a distinctive family of
F-actin-binding proteins. The C-terminal half of cortactin consists of
a predicted
-helix of 50 to 60 residues, a region enriched in
proline, serine, and threonine, and a Src homology 3 (SH3) domain that
has been found in numerous signaling proteins (15). The
cortactin SH3 domain has significant sequence and topological
similarity with the SH3 domains of the cortactin-related protein HS1
(76%; discussed below), the yeast actin-binding protein 1 (53%
[24]), and the c-Abl tyrosine kinase substrate Abi2
(53% [17]). All SH3 domains characterized so far
mediate protein-protein interactions via recognition of polyproline
motifs with a left-handed helical conformation (49). The SH3
domain-mediated interactions are implicated in regulation of enzyme
activities, targeting of proteins to specific subcellular compartments,
and coupling of signaling pathways (15). Little is known
about the function of the cortactin SH3 domain except for its selective
interaction with peptides containing a consensus sequence of +PP
PXKP
(66). It is interesting to note that a cortactin-related
protein termed HS1, which is expressed exclusively in hematopoietic
cells (40), contains three and a half copies of a
37-amino-acid motif in the N-terminal region and an SH3 domain at the
distal C terminus. Each unit of the repeats and the SH3 domain of HS1
display approximately 70% sequence identity to analogous regions in
cortactin, whereas sequence similarity in other regions is limited
(40, 41). Proliferative responses and clonal deletion of B
cells and T cells upon antigen receptor cross-linking are significantly
impaired in mice lacking HS1, implicating important roles of HS1 in
antigen receptor-initiated signaling processes (70).
Studies of tyrosine phosphorylation and intracellular distribution of
cortactin have suggested involvement of cortactin in signaling pathways
induced by oncogenic transformation and cell surface activation. In a
number of nontransformed adherent cells grown in culture, cortactin
localizes to poorly defined punctate structures in the cytoplasm and
within F-actin-based lamellipodia and membrane ruffles at the cell
cortex (73, 78). Lamellipodia and membrane ruffles are
veil-like membrane structures that have been implicated in guiding the
migration of motile fibroblasts and of the neuronal growth cones
(59). Cortactin is normally phosphorylated on serine and
threonine, but it becomes heavily phosphorylated on tyrosine in
oncogenic pp60src-transformed fibroblasts
(39, 77). Src-induced transformation causes accumulation of
cortactin and F-actin in podosomes (77), which are labile
cell substratum adhesion sites in the transformed cells
(71). Overexpression of cortactin and redistribution of cortactin into podosome-like structures (56, 61, 63) have been observed in human carcinoma cells with amplification of the chromosome 11q13 region in which the human cortactin gene is located (61). Since podosomes contain a substratum-degrading
proteolytic activity (12) and amplification of the 11q13
region is correlated with poor tumor prognosis (50, 62),
cortactin is suggested to be involved in upregulating an invasive and
metastatic behavior associated with tumors with 11q13 amplification
(63). In addition, a transient increase in
tyrosyl-phosphorylated cortactin is induced by a variety of types of
cell surface activation, including treatment of fibroblasts with growth
factors (23, 79), activation of platelets with thrombin
(76), activation of intercellular adhesion molecule 1 in
brain endothelial cells (25), and invasion of epithelial
cells by Shigella flexneri (19). All these
cellular processes involve dramatic changes in the cortical
cytoskeleton, and translocation of cortactin to specific cortical
cytoskeleton structures has been observed in response to some of these
external stimuli. For example, during S. flexneri-mediated
cell invasion, which requires assembly of F-actin at the bacterial
entry sites (14), cortactin coaccumulates with F-actin in
the membrane ruffles at the sites of bacterial entry and in the
periphery of the early phagosomes (19).
Given its multidomain structure and regulated subcellular localization,
cortactin has been suggested to recruit other signaling molecules to
the cortical cytoskeleton (25, 53, 76, 78). In this study,
we have identified a novel cortactin-binding protein of approximately
180 kDa, which is designated CortBP1 for cortactin-binding protein 1. A
consensus sequence for cortactin SH3 domain-binding peptides
(66) is present in the CortBP1 sequences, and the cortactin SH3 domain is required and sufficient for the interaction with CortBP1.
The C terminus of CortBP1 contains a sterile alpha motif (SAM), which
has been found in a number of signaling proteins involved in
developmental regulation (60). CortBP1 is expressed predominately in brain tissue as determined by both Northern and Western blot analysis. Immunofluorescence studies revealed
colocalization of CortBP1 with cortactin and cortical F-actin in
lamellipodia and membrane ruffles in fibroblasts overexpressing
CortBP1. Colocalization of endogenous CortBP1 and cortactin was
observed in growth cones in differentiating hippocampal neurons. These
data place CortBP1 and cortactin in the same subcellular compartment
and implicate a possible involvement of CortBP1 and cortactin in the
dynamic actin reorganization during neuronal growth cone extension.
 |
MATERIALS AND METHODS |
DNA constructs.
To generate the construct pPC97-SR5,
expressing the cortactin SH3 domain fused to the GAL4 DNA-binding
domain (GAL4 BD), the mouse cortactin cDNA clone mp85.L7
(51) was amplified by PCR with primers 1597 (5'-GTCCCCCGGGCATCACAGCCATCGCC-3') and 1786 (5'-CCGGAATTCTGGGTGGCAGCCCTACT-3'). The resultant PCR
product was inserted as an SmaI/EcoRI fragment
into pPC97 (13). The expression construct for GAL4
BD-cortactinSH3W525K was generated by subcloning the
BglII/NotI fragment (amino acids 506 to 546) of
pFlag-cortactinW525K (described below) into
BglII/NotI-digested pPC97-SR5.
To express full-length CortBP1 in mammalian cells, pcDNA3.6 and
pcDNA3.2 were generated by subcloning the NotI-digested
inserts of phage DNA clones 6.b and 2.b (see Fig. 2A) into
NotI-excised pcDNA3.1(
) (Invitrogen). The full-length
CortBP1 cDNA, pcDNA3.62, was then made by subcloning the 2.4-kb
EcoRV/BamHI fragment of pcDNA3.2 into
EcoRV/BamHI-digested pcDNA3.6 construct.
The glutathione
S-transferase (GST)-CortBP1 construct
pGEX-CortBP1cte was generated by subcloning the
SalI/
NotI insert of
pPC86-2H (amino acids 941 to
1252) into pGEX4T-2 (Pharmacia Biotech).
For expression of CortBP1cte
in mammalian cells, pRK5-CortBP1cte
was engineered by subcloning the
BamHI fragment of pGEX-CortBP1cte
into pRK5myc
(
54). The resultant construct encoded Myc-CortBP1cte
recombinant protein that contained the 10-amino-acid Myc epitope
tag
(EQKLISEEDL) fused to the N terminus of CortBP1cte.
pFlag-cortactin, the Flag-tagged cortactin construct, was generated by
PCR with primers 17676 (5'-GGTACCATGTGGAAAGCCTCTGCAGGC-3')
and 17677 (5'-GAATTCCTACTGCCGCAGCTCCACATAG-3'), which
flank the
open reading frame of the mouse cortactin cDNA clone mp85.L7
(
51).
The resultant PCR product was subcloned into
pCR-Script (Stratagene),
digested with
KpnI and
EcoRI, and subcloned into pcDNA3Flag2AB
(
20).
pFlag-cortactin W525K was then generated by mutagenizing
pFlag-cortactin with primer pairs
(5'-GAAATGATTGACGATGGC
AAGTGGCGTGGGGTGTGCAAG-3'
and
5'-CTTGCACACCCCACGCCA
CTTGCCATCGTCAATCATTTC-3')
with the QuickChange
site-directed mutagenesis kit (Stratagene).
The coding regions
of all constructs were confirmed by direct DNA
sequence analysis.
Yeast two-hybrid analysis, cDNA cloning, and sequence
analysis.
Transformation of yeast strain Y190 (34) was
performed by the lithium acetate method (29), and
-galactosidase activity in individual transformants was measured by
the filter lift assay (4). Initially, five variants of
cortactin fused to GAL4 BD were generated as baits. However, Y190 cells
harboring each of four constructs which encoded full-length proteins or
the C-terminal regions (amino acids 329 to 546, 396 to 546, or 473 to
546) exhibited readily detectable
-galactosidase activity. A
construct, pPC97-SR5, lacking the 17-amino-acid sequence
(473-GHYQAEDDTYDGYESDL-489) common to the four
transactivating constructs did not induce any
-galactosidase
activity and was used to screen a rat brain library. Yeast
transformants containing pPC97-SR5 were subsequently transformed with a
rat hippocampus cDNA library in pPC86 (13) and selected for
growth on Leu
Trp
His
plates
with 25 mM 3-aminotriazole. Three independent positive clones that
showed detectable
-galactosidase activity within 12 h of
analysis were identified from 5 × 105 yeast
transformants and purified by three rounds of colony purification. Loss
of pPC97-SR5 from purified positive colonies was induced by
Trp
selection, and positive library plasmids were
isolated. To verify the interaction, purified positive plasmids were
retransformed into Y190 cells together with pPC97, pPC97-SR5, or
pPC97-SR5W525K, and resultant transformants were analyzed for
-galactosidase activity.
To obtain the full-length cDNA sequence for CortBP1, a

gt11 rat
brain cDNA library (Clontech) was screened with an
[

-
32P]CTP-labeled 0.87-kb
SalI/
BglII fragment of insert 2H (see Fig.
2A).
Subsequently, a 5' 0.88-kb
EcoRI-digested fragment derived
from clone 10.a (see Fig.
2A) was labeled with
[

-
32P]CTP and used as probe to screen a
5'-plus-stretch rat hippocampus
library in

gt11 (Clontech) until
clones (clones 6.b and 7.b [Fig.
2A]) containing 5' in-frame stop
codons were isolated. Throughout
the complete coding region, at least
two independent clones of
the same region were sequenced on both
strands. DNA sequence was
obtained by the dideoxy chain termination
method. Both DNA and
amino acid sequences were analyzed with Genetics
Computer Group
sequence analysis software.
Northern blot analysis.
A 0.87-kb
SalI-BglII fragment of insert 2H, a 1.25-kb
EcoRI-SacI fragment of the mouse cortactin cDNA
clone mp85.L7 (51), and a
-actin cDNA probe (Clontech)
were labeled with [
-32P]CTP by primer extension with
random hexamernucleotide primer (Pharmacia Biotech). A multiple-tissue
Northern blot (Clontech), each lane of which contains approximately 2 µg of poly(A)+ RNA from specific adult mouse tissues, was
incubated with each probe (2 × 108 to 5 × 108 cpm/µg) overnight at 42°C. The filter was then
washed twice (5 min) in washing buffer 1 (2× SSC [1× SSC is 0.15 M
NaCl plus 0.015 M sodium citrate], 0.1% sodium dodecyl sulfate
[SDS]) at room temperature, twice (5 min) in washing buffer 2 (0.2×
SSC, 0.1% SDS) at room temperature, and then twice (15 min) in
prewarmed washing buffer 2 at 42°C. After each hybridization, the
probe was stripped by incubating the filter in boiled 0.5% SDS for 10 min and then in 2× SSC for 5 min at room temperature.
GST fusion proteins and in vitro binding analysis.
GST
fusion proteins were expressed and purified as described elsewhere
(65). Briefly, 5 ml of clarified lysates from
Escherichia coli BL21 expressing GST fusion proteins in NETN
(20 mM Tris-HCl [pH 8.0], 100 mM NaCl, 1 mM EDTA, 0.5% Nonidet P-40,
50 µg of leupeptin per ml, 1 mM phenylmethylsulfonyl fluoride, 0.05 U
of aprotinin per ml) was incubated with 200 µl of 50%
glutathione-Sepharose bead slurry (Pharmacia Biotech) at 4°C for
1 h with constant rocking. The beads were then washed three times
with 1 ml of NETN. To make antigen for CortBP1-specific antiserum,
purified GST-CortBP1cte proteins were eluted by incubating the beads
with glutathione elution buffer (20 mM reduced glutathione, 120 mM
NaCl, 100 mM Tris-HCl, pH 8.0) at room temperature for 10 min with
constant rocking. The eluates were then dialyzed against
phosphate-buffered saline (PBS) and concentrated to approximately 1 mg/ml.
For in vitro binding experiments, immobilized GST fusion proteins were
mixed with 1 ml of 1-mg/ml cell lysates in modified
radioimmunoprecipitation assay buffer (RIPA) (50 mM HEPES [pH
7.2],
150 mM NaCl, 2 mM EDTA, 0.5% sodium deoxycholate, 1% Nonidet
P-40, 50 µg of leupeptin per ml, 1 mM phenylmethylsulfonyl fluoride,
0.05 U of
aprotinin per ml, 1 mM sodium vanadate, 40 mM sodium
fluoride) at 4°C
for 2 to 3 h. After being washed once with 1
ml of modified RIPA
and three times with 1 ml of HNTG (20 mM HEPES
[pH 7.0], 150 mM NaCl,
0.1% Triton X-100, 10% glycerol), precipitated
proteins were
subjected to Western blot analysis with the cortactin-specific
MAb
4F11.
Antibodies and immunoprecipitation analysis.
Rabbit
polyclonal antiserum (anti-CortBP1) was raised against purified
GST-CortBP1cte (amino acids 941 to 1252). Both anti-CortBP1 and
preimmune serum were protein G purified. The specificity of anti-CortBP1 against CortBP1 was confirmed as follows: 500 µg of
lysates from NIH 3T3 cells overexpressing Myc epitope-tagged CortBP1cte
was immunoprecipitated with anti-CortBP1, preimmune serum, or the
Myc-specific MAb 9E10. Precipitated proteins were resolved on SDS-12%
polyacrylamide gel electrophoresis (PAGE) gels and subjected to Western
blot analysis with anti-CortBP1. Anti-CortBP1 recognized a species
present in the immunocomplex of anti-CortBP1 but not in preimmune
immunocomplex that comigrated with the recombinant protein present in
the immunocomplex of MAb 9E10. Direct Western blot analysis of 100 µg
of rat brain lysate revealed a major polypeptide of approximately 180 to 200 kDa (see Fig. 8A) and a minor peptide species of approximately
75 kDa (data not shown).
The cortactin-specific polyclonal antibody, anti-Cterm, was generated
by purifying rabbit antiserum raised against a GST-cortactin
fusion
protein (GST.p80 [
78]) by using a cyanogen
bromide-Sepharose
4B column (Pharmacia) coupled with a GST fusion
protein of the
C-terminal half of mouse cortactin (amino acids 329 to
546 [
73]).
The cortactin-specific MAb 4F11 has been
previously described
(
39). Mouse MAbs specific for NCK
(anti-NCK), for the Myc epitope
(9E10), and for the Flag epitope (M5)
were purchased from Transduction
Laboratories, Santa Cruz
Biotechnology, and Sigma, respectively.
For immunoprecipitating CortBP1, 5 to 10 µg of protein G-purified
anti-CortBP1 or preimmune serum was incubated with 500 µl
of modified
RIPA containing 50 µl of protein A-Sepharose beads
(Sigma) at 4°C
for 1 h, followed by three washes with 1 ml of
modified RIPA.
Tissue extracts prepared by homogenizing adult
male rat
(Sprague-Dawley) tissues in modified RIPA containing
0.05% SDS or cell
lysates were incubated with immobilized anti-CortBP1
or preimmune
antiserum at 4°C for 2 to 3 h. After three washes
with 1 ml of
modified RIPA, immunoprecipitates were subjected
to Western blot
analysis with 1 µg of the MAb 4F11 per ml, 5 µg
of anti-CortBP1 per
ml, or 250 ng of the MAb anti-NCK per ml.
Cell culture, transfection, and immunofluorescence
microscopy.
NIH 3T3 cells were maintained in Dulbecco's modified
Eagle's medium containing 10% fetal bovine serum and
penicillin-streptomycin. Both 10T1/2neo cells, which are a stable
transfectant of C3H-10T1/2 murine fibroblasts with pSV2neo, and 5Hd47
cells (c-Src overexpressors), which are a stable transfectant of
C3H-10T1/2 cells with pSV2neo and a plasmid encoding chicken c-Src
(11), were maintained in Dulbecco's modified Eagle's
medium containing 10% fetal bovine serum, penicillin-streptomycin, and
G418. PC12 cells were cultured as described elsewhere (32).
Primary cultures of hippocampal neurons prepared from embryonic day-18
rats (5) were generously provided by Gary Banker.
Cells were transiently transfected with SuperFect (Qiagen). Thirty-six
hours posttransfection, NIH 3T3 cells transfected with
expression
constructs were lysed and subjected to further analysis.
For detection
of CortBP1 localization in fibroblasts, 10T1/2neo
or 5Hd47 cells were
seeded on glass coverslips, grown to approximately
60% confluence, and
transfected with pRK5-CortBP1cte. Sixteen
hours posttransfection, cells
were fixed and processed for immunofluorescence
analysis.
For immunofluorescence experiments, cultured fibroblasts were fixed
with 4% paraformaldehyde in PBS for 20 min and permeabilized
with
0.5% Triton X-100 in PBS for 3 min. Cultured hippocampal
neurons were
fixed and permeabilized with methanol for 20 min.
After three washes
with PBS, cells were blocked with 20% goat
serum-2% bovine serum
albumin in PBS for 1 h and incubated with
primary antibodies (2.0 to 5.0 µg of anti-CortBP1 per ml, 5 µg
of preimmune serum per ml,
0.2 µg of 9E10 per ml, 1 to 2 µg of
4F11 per ml, or 1.0 µg of
anti-Cterm per ml) in PBS containing
10% goat serum and 1% bovine
serum albumin for 1 h. After three
washes with PBS, cells were
then incubated with 1.5 µg of fluorescein
isothiocyanate- or Texas
Red-conjugated secondary antibodies (goat
anti-rabbit or goat
anti-mouse [Jackson ImmunoResearch]) per ml
for 45 min. To visualize
F-actin, 0.4 U of Texas Red-conjugated
phalloidin (Molecular Probes)
per ml was coincubated with secondary
antibodies. For the antigen
blocking experiment, 5 µg of anti-CortBP1
per ml was preincubated
with 5 µg of purified GST-CortBP1cte per
ml for 2 h at room
temperature prior to labeling. Cells were viewed
with a Leitz DMR
fluorescence microscope and photographed with
a cooled charge-coupled
device camera controlled by the ISee software
program (Inovision).
Images were processed on a Macintosh computer
with Adobe Photoshop.
Nucleotide sequence accession number.
The nucleotide
sequence of the CortBP1 cDNA (nucleotides 1 to 4636) has been given the
GenBank accession no. AF060116.
 |
RESULTS |
Identification and molecular cloning of cortactin-binding protein
1.
To better define the role of cortactin in cell signaling
events, we utilized the yeast two-hybrid system (28) to
isolate cDNA clones encoding cortactin-binding proteins. With GAL4
BD-cortactinSH3 as the bait (Fig. 1A),
three unique positive clones were isolated from a rat hippocampus cDNA
library. The clone pPC86-2H, which reproducibly exhibited the highest
affinity for the bait (data not shown), was further characterized. The
identified interaction was dependent upon the SH3 domain since the
GAL4 BD alone or GAL4 BD-cortactinSH3W525K, in which a tryptophan
residue highly conserved in SH3 domains (69) was replaced
with a lysine residue, did not display any detectable interaction with
the fusion protein encoded by pPC86-2H (Fig. 1B).

View larger version (31K):
[in this window]
[in a new window]
|
FIG. 1.
Identification of cortactin SH3 domain-interacting
proteins. (A) Diagram of cortactin domain structure and the cortactin
SH3 domain expressed as a GAL4 BD (denoted by hatched oval) hybrid. The
tandem repeats in the N-terminal half are denoted by solid boxes; the
predicted -helical region, the proline/serine/threonine-rich region,
and the SH3 domain are denoted by -H, PST, and SH3, respectively.
The numerical positions of amino acid residues of mouse cortactin are
also indicated. The N-terminal half is designated nte, and the
C-terminal half is designated cte. (B) Analysis of the CortBP1 and
cortactin SH3 domain interaction by the two-hybrid assay. Y190 cells
were cotransformed with pPC86-2H and pPC97 (lane 1), pPC86-2H and
pPC97-SR5W525K (lane 2), or pPC86-2H and pPC97-SR5 (lane 3). The
resultant transformants were subjected to the filter lift assay for
12 h.
|
|
Sequence analysis revealed that pPC86-2H contained an insert (2H) of
approximately 2.5 kb with a predicted open reading frame
of 312 amino
acids contiguous with the GAL4 BD (Fig.
2A and B).
Neither the
DNA nor the deduced amino acid sequence had significant
overall
homology to any sequences in current databases. However,
a proline-rich
sequence (KPPVPPKP, hereafter referred to as the
ppI motif) was found
by inspection of the predicted amino acid
sequence. The ppI motif
showed striking similarity to the consensus
sequence for cortactin SH3
domain-binding peptides (
66), matching
at all seven
positions (Fig.
2D) that are predicted to be SH3
domain-contacting-scaffolding residues (
27). In addition,
the
last 67 amino acids of this polypeptide showed extensive similarity
to SAM domains (Fig.
2C), 60- to 70-amino-acid sequence motifs
with a
predicted secondary structure consisting of four short

-helices
linked by loops (
58). SAM domains have been identified
in a
variety of proteins (
60) including EPH family receptor
tyrosine kinases, yeast sterile proteins including the serine/threonine
kinases Byr2p and Ste11p, the

subunit of trimeric G protein
Ste4p,
and the cytoskeleton-associated proteins Boi1p and Boi2p,
as well as
several
Drosophila proteins involved in developmental
regulation. As the first reported natural ligand for the cortactin
SH3
domain, this protein was designated CortBP1 for cortactin-binding
protein 1.

View larger version (40K):
[in this window]
[in a new window]
|
FIG. 2.
Amino acid sequence and homology domains of CortBP1. (A)
Structure of CortBP1 cDNA clones. The CortBP1 cDNA, assembled from the
sequences of partial CortBP1 cDNA clones, is illustrated as a line with
the positions of the predicted translation initiation and termination
codons indicated. Also shown are the positions of restriction sites
used for analysis and subcloning, including EcoRI (RI),
BglII (Bg), EcoRV (RV), and BamHI
(Ba). The relative positions of the 5' ends of nine partial cDNA clones are
indicated at the left. Clones 15.a, 25.a, and 10.a were isolated from a
rat hippocampus cDNA library, whereas clones 17.b, 14.b, 2.b, 7.b, and
6.b were from a rat brain 5'-stretch-plus cDNA library. (B) Deduced
amino acid sequence of CortBP1. The residues encoded by the two-hybrid
cDNA clone 2H are shaded. The SAM domain is underlined, and the ppI
motif is indicated by dots. (C) Alignment of the predicted SAM domain
of CortBP1 with related SAM domains. The boxed amino acid residues are
identical or conserved in more than 70% of the SAM domains compared.
The gaps in the alignment are denoted by dots. , aliphatic residues;
, aromatic residues. (D) Comparison of the CortBP1 ppI motif, the
consensus for cortactin SH3 domain-binding peptides, and the consensus
for class II ligands of SH3 domains. Predicted SH3-contacting residues
are capitalized. +, R or K; , aliphatic residues; x, any amino acid
residue.
|
|
To obtain the complete cDNA sequence of CortBP1, two rat brain cDNA
libraries were sequentially screened. Eight overlapping
partial cDNAs
were isolated, and selected regions of these cDNAs
were sequenced (Fig.
2A). The 5'-most cDNA clones, 6.b and 7.b
(Fig.
2A), contained an
in-frame methionine codon (nucleotides
425 to 427) that was preceded by
translational termination codons
in all three reading frames. The first
predicted ATG conformed
to the canonical Kozak sequence
(
42), matching at positions

3,

4, and

5. The predicted
termination codon (nucleotides 4181
to 4183) was present in two
additional clones (clone 15.a and
clone 2.b [Fig.
2A]). The 3'-most
cDNA clone, clone 2.b, contained
a 3' untranslated region of
approximately 2.7 kb. However, neither
a polyadenylation signal
(
75) nor a polyadenosine sequence was
found at the 3' end of
clone 2.b, implicating an even longer 3'
noncoding sequence.
The CortBP1 open reading frame, deduced from sequences of the partial
cDNA clones, encoded a 1,252-amino-acid protein with
a calculated
molecular mass of 134 kDa (Fig.
2B). The deduced
N-terminal 940 residues of CortBP1 5' cDNA did not show significant
overall similarity
to any identified proteins in the existing
databases. Amino acid
composition analysis revealed that the CortBP1
protein is considerably
rich in proline and serine residues (12
and 10%, respectively).
Tissue distribution analysis of the CortBP1 transcript.
To
investigate the tissue distribution of the CortBP1 expression, a
CortBP1 cDNA fragment (nucleotides 3245 to 4111) derived from the clone
2H was used to probe a mouse multiple-tissue Northern blot. A major
mRNA species of approximately 8 kb was detected exclusively in brain
tissue, whereas a much less abundant species of approximately 9.5 kb
was detected in brain, kidney, liver, and lung tissue (Fig.
3A). No hybridization to mRNAs from
heart, spleen, skeletal muscle, and testis tissue was detected.
Northern blot analysis using two other independent probes (from cDNA 2H and clone 10.a) that represented different regions of CortBP1 cDNA
yielded identical results (data not shown).

View larger version (64K):
[in this window]
[in a new window]
|
FIG. 3.
Tissue distribution of CortBP1 mRNA and cortactin mRNA.
A blot containing poly(A)+ RNA from multiple mouse tissues
was hybridized with a CortBP1 cDNA fragment (A), a mouse cortactin cDNA
fragment (B), or a -actin cDNA fragment (C) as described in
Materials and Methods. Lanes: 1, heart; 2, brain; 3, spleen; 4, lung;
5, liver; 6, skeletal muscle; 7, kidney; 8, testis. The positions of
markers of known size (kilobases) are indicated at the left.
|
|
Previous studies have shown that the cortactin gene is widely expressed
in murine tissues (
51). In order to compare the
expression
pattern of the cortactin gene with that of the CortBP1
gene, the same
RNA blot was rehybridized with a mouse cortactin
cDNA probe (Fig.
3B).
Both cortactin and CortBP1 mRNAs were expressed
at high levels in brain
tissue, whereas little or no expression
of both proteins was observed
in spleen or skeletal muscle tissue.
On the other hand, cortactin was
expressed in heart, lung, liver,
and testis tissues, in which little
CortBP1 mRNA expression was
detected.
Expression of the CortBP1 protein.
To characterize the
endogenous CortBP1 protein, a rabbit polyclonal serum (anti-CortBP1)
was raised against the C-terminal region (amino acids 941 to 1252) of
CortBP1 (CortBP1cte) as described in Materials and Methods. CortBP1
expression in a number of adult rat tissues was then assessed by
immunoprecipitation and Western blot analysis with anti-CortBP1. As
shown in Fig. 4A, a protein of
approximately 180 kDa was detected in brain lysates while preimmune serum showed no reactivity with this protein (data not shown). Interestingly, no immunoreactive bands were detected in the other tissues examined, including heart, spleen, lung, liver, skeletal muscle, kidney, and testis. Analysis of several cell lines revealed expression of the CortBP1 protein in the rat adrenal pheochromocytoma cell line PC12, whereas expression of p180 CortBP1 was undetectable in
the rat fibroblast cell line RAT1 (Fig. 4B) or in mouse NIH 3T3 cells
(Fig. 4C, lane 5).

View larger version (42K):
[in this window]
[in a new window]
|
FIG. 4.
Expression of the CortBP1 protein. (A and B)
Distribution of the CortBP1 protein in lysates from rat tissues and
cell lines. Lysate (1.0 mg) derived from eight adult rat tissues (A) or
RAT1 or PC12 cells (B) was incubated with anti-CortBP1 or preimmune
serum. Cellular proteins in the immunocomplexes were subjected to
Western blot analysis with anti-CortBP1. (A) Lane 1, heart; lane 2, brain; lane 3, spleen; lane 4, lung; lane 5, liver; lane 6, skeletal
muscle; lane 7, kidney; lane 8, testis. (C) Expression of full-length
CortBP1 in NIH 3T3 cells. Five hundred micrograms of lysates from NIH
3T3 cells (lane 5), NIH 3T3 cells transfected with pcDNA3.1 (lane 6),
or NIH 3T3 cells transfected with pcDNA3.62 (lanes 1, 2, 7, and 8) or
1.0 mg of lysates from PC12 cells (lanes 3 and 9) or rat brain (lanes 4 and 10) was incubated with anti-CortBP1 (lanes 5 to 10) or preimmune
serum (lanes 1 to 4). Precipitated proteins were subjected to Western
blot analysis with anti-CortBP1. The positions of molecular mass
markers are indicated in kilodaltons at the left of each panel. The
positions of p180 CortBP1 and the heavy chain of immunoglobulin G are
indicated with arrowheads and arrows, respectively. IP,
immunoprecipitation; IB, immunoblotting.
|
|
Since the relative molecular mass of CortBP1 determined by SDS-PAGE was
much greater than the molecular mass calculated from
the predicted
amino acid sequence, a construct (pcDNA3.62) comprising
the entire
predicted coding sequence was generated from clone
6.b and clone 2.b,
subcloned into the expression vector pcDNA3.1,
and transfected into NIH
3T3 cells. As shown in Fig.
4C, lysates
from cells transfected with
pcDNA3.62 contained a major species
that comigrated with the major
CortBP1-immunoreactive band in
PC12 and rat brain lysates. No
immunoreactive band of the appropriate
size was detected in lysates
from nontransfected or pcDNA3.1-transfected
cells. Based on this
result, we conclude that the open reading
frame deduced from the
isolated CortBP1 cDNA clones contains the
complete coding region for
p180 CortBP1.
Characterization of the interaction between CortBP1 and
cortactin.
The identification of CortBP1 by two-hybrid screening
indicated an interaction between the cortactin SH3 domain and the
CortBP1cte containing the ppI motif. To further explore the interaction
between CortBP1 and cortactin, we examined the ability of
GST-CortBP1cte to associate with endogenous cortactin in NIH 3T3 cell
lysates. GST, GST-CortBP1cte, or GST-FAKcte (amino acids 687 to 1054 [35]) fusion proteins were coupled to
glutathione-Sepharose beads and incubated with NIH 3T3 cell lysates.
GST-FAKcte was used as a control to specify the interaction since the
FAKcte polypeptide contains two class II SH3 ligand motifs that have
been shown to serve as the binding sites for the SH3 domains of
p130cas and Graf (35, 37). The amount
of cortactin bound to immobilized GST fusion proteins was then
determined by Western blot analysis with the cortactin-specific MAb
4F11. As shown in Fig. 5A, cortactin coprecipitated with immobilized GST-CortBP1cte fusion proteins in a
dose-dependent manner whereas little cortactin coprecipitated with
beads coated with either GST alone or GST-FAKcte.

View larger version (28K):
[in this window]
[in a new window]
|
FIG. 5.
Interaction between CortBP1 and cortactin. (A) Specific
interaction of GST-CortBP1cte with cortactin in NIH 3T3 cell lysates.
Two (lanes 1, 3, and 5) or five (lanes 2, 4, and 6) micrograms of each
immobilized GST fusion protein was incubated with 600 µg of NIH 3T3
cell lysates. Precipitated cellular proteins were subjected to Western
blot analysis with the anti-cortactin MAb 4F11. Lane 7 contains 30 µg
of total NIH 3T3 cell lysate. The arrowhead indicates the position of
cortactin. (B) Requirement for a functional cortactin SH3 domain for
CortBP1 interaction. Five micrograms of GST-CortBP1cte protein was
mixed with 700 µg of lysates from NIH 3T3 cells expressing
Flag-tagged wild-type cortactin (lane 1) or cortactin SH3 mutant (lane
2). The protein complexes were collected by centrifugation and analyzed
by Western blot analysis with the Flag-specific MAb M5. As loading
controls, 50 µg of cell lysates expressing wild-type and mutant
cortactin was loaded in lanes 3 and 4, respectively. (C) In vivo
interaction of CortBP1 and cortactin in PC12 cells. Seven hundred
micrograms of PC12 cell lysates was incubated with anti-CortBP1 (lanes
1) or preimmune serum (lanes 2). Immunocomplexes were subjected to
Western blot analysis with 4F11 (top panel) and subsequently with an
anti-NCK MAb (bottom panel). Lanes 3 were loaded with 100 µg of total
PC12 cell lysates. IB, immunoblotting; IP, immunoprecipitation.
Arrowhead, position of cortactin; arrow, position of NCK.
|
|
To assess the requirement of the cortactin SH3 domain for interacting
with CortBP1, we compared the ability of GST-CortBP1cte
to bind to an
epitope (Flag)-tagged full-length cortactin and
to a Flag-tagged
cortactinW525K mutant expressed in NIH 3T3 cells.
Lysates from cells
transfected with pFlag-cortactin contained
two major species that were
reactive with the Flag epitope-specific
MAb M5 (Fig.
5B). In contrast,
pFlag-cortactinW525K-transfected
cell lysates contained only one major
species comigrating with
the slower-migrating form of the wild-type
cortactin (Fig.
5B,
lanes 3 and 4), implicating a conformational change
resulting
from the point mutation in the SH3 domain. Little
cortactinW525K
was pulled down by immobilized GST-CortBP1cte fusion
proteins,
whereas wild-type cortactin was readily detected in the
precipitated
complex (Fig.
5B, lanes 1 and 2), indicating the
requirement for
SH3 domain integrity for mediating interaction with
CortBP1.
To assess the ability of endogenous CortBP1 to bind cortactin, the in
vivo interaction between CortBP1 and cortactin was examined
in
undifferentiated PC12 cells in which both proteins are expressed.
PC12
cell lysates were incubated with either anti-CortBP1 or preimmune
serum, and cortactin present in the immunocomplexes was detected
by
Western blot analysis with the MAb 4F11. Approximately 5 to
15% of the
cortactin present in PC12 cell lysates was reproducibly
recovered in
the anti-CortBP1 immunocomplex, whereas no detectable
cortactin was
present in preimmune complex (Fig.
5C). When the
same protein blot was
probed with a MAb specific for NCK (an unrelated
SH3-containing protein
[
44]), no NCK protein could be detected
in the CortBP1
immunocomplex (Fig.
5C). Similar results were obtained
with PC12 cells
differentiated by treatment with nerve growth
factor for 1 to 60 min or
1 to 9 days (data not shown). Thus,
both in vitro and in vivo protein
interaction analysis confirmed
the association of cortactin with
CortBP1.
Subcellular localization of ectopically expressed CortBP1 in
fibroblasts.
Previous studies have shown that a significant
portion of cortactin colocalizes with F-actin-containing structures
including lamellipodia and membrane ruffles in fibroblasts as well as
in podosomes in Src-transformed fibroblasts (77, 78). To
assess whether CortBP1 would colocalize with cortactin present in the cortical cytoskeleton, Myc epitope-tagged CortBP1cte (Fig.
6A) was expressed in 10T1/2 cells and
10T1/2 cells overexpressing c-Src (10T1/2-c-Src). Localization of
CortBP1 was determined by immunofluorescence staining with either
anti-CortBP1 or Myc epitope-specific MAb 9E10. In 10T1/2 cells
overexpressing CortBP1, both antibodies revealed intense staining of
CortBP1 within lamellipodia and membrane ruffles (Fig. 6B [a and b]).
Accumulation of CortBP1 at the cell cortex was most prominent at the
leading and trailing edges of motile cells (Fig. 6B and
7). These lamellipodia and membrane ruffles were enriched with F-actin as shown by costaining experiments with phalloidin (Fig. 6B [e and f]). Little background staining was
detected in untransfected cells with either anti-CortBP1 (Fig. 7a and
b) or MAb 9E10 (Fig. 6B [e and f]). Similar staining patterns of
CortBP1 were also observed in two other fibroblast cell lines, REF52
and Swiss 3T3, overexpressing CortBP1cte (data not shown). When
expressed in 10T1/2-c-Src cells, CortBP1 accumulated in dot-like structures in the peripheral extensions in some cells as well as
throughout the cytoplasm in others (Fig. 6B [c and d]). As shown in
Fig. 6B (g and h), these dot-like structures were enriched with F-actin
and are likely membrane-substratum contact sites similar to podosomes
(77).

View larger version (48K):
[in this window]
[in a new window]
|
FIG. 6.
Colocalization of CortBP1cte and cortical F-actin in
10T1/2 cells. (A) Diagram of Myc epitope-tagged CortBP1cte. The MAb
9E10 is directed to the Myc epitope, and anti-CortBP1 recognizes
CortBP1cte. (B) Intracellular distribution of CortBP1 in 10T1/2 and
10T1/2-c-Src cells. 10T1/2 (a, b, e, and f) or 10T1/2-c-Src (c, d, g,
and h) cells were transfected with the Myc-CortBP1cte expression vector
and fixed 16 to 18 h posttransfection. Localization of CortBP1 in
individual cells was detected with either anti-CortBP1 (a and c) or
9E10 (b and d). Transfected cells were also stained with 9E10 (e and g)
in combination with fluorescently conjugated phalloidin (f and h) to
visualize the colocalization of CortBP1 and F-actin. Arrowheads
indicate lamellipodia and membrane ruffles in 10T1/2 cells and
podosome-like structures in 10T1/2-c-Src cells. Bar, 20 µm.
|
|

View larger version (58K):
[in this window]
[in a new window]
|
FIG. 7.
Colocalization of CortBP1 and cortactin in 10T1/2 cells.
10T1/2 (a to d) and 10T1/2-c-Src (e to h) cells were transfected with
the Myc-CortBP1cte expression vector and fixed 16 to 18 h
posttransfection. Cells were then immunostained either with
anti-CortBP1 in combination with the anti-cortactin MAb 4F11 (a, b, e,
and f) or with 9E10 in combination with the cortactin-specific antibody
anti-Cterm (c, d, g, and h). Arrowheads indicate lamellipodia and
membrane ruffles in 10T1/2 cells and podosome-like structures in
10T1/2-c-Src cells. Bar, 20 µm.
|
|
To confirm the colocalization of CortBP1 with cortactin, cells
overexpressing CortBP1 were stained with anti-CortBP1 in combination
with the MAb 4F11 (Fig.
7a, b, e, and f) or, alternatively, with
9E10
in combination with the cortactin-specific polyclonal antibody
anti-Cterm (Fig.
7c, d, g, and h). As shown in Fig.
7, significant
costaining of CortBP1 and cortactin was observed in lamellipodia
and
membrane ruffles in 10T1/2 cells and in podosome-like structures
in
10T1/2-c-Src cells. These data confirmed the colocalization
of CortBP1
and cortactin within subcellular compartments enriched
with cortical
F-actin.
Analysis of CortBP1 and cortactin in differentiating hippocampal
neurons.
The intense costaining of CortBP1 and cortactin within
the lamellipodia and membrane ruffles prompted our studies of the
intracellular distribution of these two proteins in differentiating
neurons which contain similar F-actin cortical structures in growth
cones (45). To find neurons expressing both proteins, we
first examined the expression levels of cortactin and CortBP1 in brain
lysates isolated from rats at different developmental stages. Western blot analysis of brain lysates revealed that the expression levels of
CortBP1, the major bands recognized by anti-CortBP1 (data not shown),
increased during the course of embryonic development and remained at
high levels during postnatal development (Fig.
8A). In contrast, the expression level of
cortactin in rat brain was relatively constant at all of the nine
developmental stages examined (Fig. 8A). Since expression of both
CortBP1 and cortactin is readily detected in the embryonic 18-day rat
brain lysates, in vitro-cultured neurons explanted from embryonic
18-day rat hippocampus were used to assess the subcellular localization
of CortBP1 and cortactin by indirect immunofluorescence with the
CortBP1-specific anti-CortBP1 and the cortactin-specific MAb 4F11.
After 24 h in culture, a majority of cells displayed extended
neurites with defined growth cone structures as previously described
(31). At this stage, cortactin displayed intense staining
within growth cones and weaker staining in the periphery of the cell
body (Fig. 8B [a and b]). Little staining of cortactin was observed
in neurite shafts. Interestingly, CortBP1 was observed within growth
cones and the cell body (Fig. 8B [c and d]). Preincubation of
anti-CortBP1 with purified antigen effectively blocked the staining in
growth cones, leaving residual fluorescence within the cell body (Fig.
8B [g and h]). Staining of the cell body but not growth cones was
seen with preimmune serum (Fig. 8B [e and f]). The staining patterns
of cortactin and CortBP1 within growth cones are very similar in that
they primarily localized at the central portion of growth cones.
Coimmunostaining analysis further suggested the colocalization of
CortBP1 and cortactin within growth cones (Fig.
9). These experiments clearly indicate that endogenous cortactin and CortBP1 reside in the same intracellular compartment in outgrowing neurites, supporting a direct interaction of
these two proteins in vivo.

View larger version (50K):
[in this window]
[in a new window]
|
FIG. 8.
(A) Expression pattern of CortBP1 and cortactin in rat
brain lysates at different developmental stages. One hundred micrograms
of lysates prepared from rat brains at the indicated developmental
stages was resolved on SDS-10% PAGE, transferred to a nitrocellulose
filter, and blotted with anti-CortBP1 (top panel). The filter was then
stripped and reblotted with the anticortactin MAb 4F11 (bottom panel).
E13, E15, and E18, embryonic days 13, 15, and 18; P1, P3, P5, P7, and
P12, postnatal days 1, 3, 5, 7, and 12. (B) Localization of cortactin
and CortBP1 in rat hippocampal neurons. Cultured hippocampal neurons
were immunostained with the anticortactin MAb 4F11 (a and b),
anti-CortBP1 (c and d), anti-CortBP1 blocked with purified antigen (g
and h), or preimmune serum (e and f). Panels b, d, f, and h are
phase-contrast images of the cells shown in panels a, c, e, and g,
respectively. Bar, 20 µm.
|
|

View larger version (46K):
[in this window]
[in a new window]
|
FIG. 9.
Colocalization of CortBP1 and cortactin in growth cones
of rat hippocampal neurons. Cultured rat hippocampal neurons were
immunostained with the anticortactin MAb 4F11 (b and e) in combination
with anti-CortBP1 (a and d). Panels c and f are phase-contrast images
of the cells shown in panels a and b and d and e, respectively. Bar, 20 µm.
|
|
 |
DISCUSSION |
Previous studies have suggested that the actin-binding protein
cortactin may mediate aspects of cell signaling associated with the
cortical cytoskeleton. The present study provides evidence that
cortactin forms an SH3 domain-dependent protein complex with a novel
180-kDa protein. This protein represents the first identified natural
ligand for the cortactin SH3 domain and is thus referred to as CortBP1.
Sequence analysis of CortBP1 revealed the presence of two readily
identifiable sequence motifs in the C-terminal region: a sequence
virtually identical to a consensus sequence defined for the cortactin
SH3 domain-binding peptides (66) and a sequence similar to
recently identified SAM domains (58). The expression pattern
of CortBP1 is restricted, being expressed predominantly in brain
tissue. The stable interaction of cortactin and CortBP1 was
demonstrated by coimmunoprecipitation of cortactin with CortBP1 in PC12
cell lysates. In addition, CortBP1, overexpressed in fibroblasts,
colocalizes with cortactin and cortical F-actin within lamellipodia and
membrane ruffles in normal cells and within podosome-like structures in
c-Src overexpressors. Colocalization of endogenous cortactin and
CortBP1 was also observed in growth cones of differentiating rat
hippocampal neurons. These data indicate that endogenous CortBP1 and
cortactin reside within the same subcellular compartment and suggest a
possible involvement of cortactin and CortBP1 in the dynamic actin
reorganization during neuritogenesis.
Data obtained by yeast two-hybrid and in vitro interaction analysis
indicate that the SH3 domain of cortactin is responsible for mediating
the observed interaction with CortBP1. Mutation of the highly conserved
tryptophan residue to lysine in the cortactin SH3 domain efficiently
blocked the interaction of full-length cortactin with CortBP1, as
evidenced by the inability of GST-CortBP1 to pull down mutant cortactin
from cell lysates. These data, coupled with the observation that mutant
SH3 domain fusions fail to bind CortBP1 in the yeast two-hybrid assay,
indicate the dependence of the interaction with CortBP1 on the
structural integrity of the cortactin SH3 domain. The critical role of
the cortactin SH3 domain for interacting with CortBP1 is further
supported by the presence of the ppI motif in CortBP1, which displays a
precise match with the consensus sequence (Fig. 2D) for cortactin SH3 domain-binding peptides. The sequence of this consensus motif, identified by screening a biased X6PXXPX6
peptide library with GST-cortactin SH3 fusion proteins, is related to
class II ligands for SH3 domains (66). Interestingly, the
cortactin SH3 domain does not show detectable interaction with peptides
preferred by SH3 domains of other proteins including Src, Yes, Abl,
Crk, Grb2, and phospholipase C
(66). The apparent
specificity of the cortactin SH3 domain may derive from two unusual
residue selections in cortactin SH3 domain-binding peptides. First,
whereas an aliphatic residue is present at the
1 position (Fig. 2D)
in most class II ligands (27), a positively charged residue
(lysine or arginine) is present at the analogous position in cortactin
SH3 domain-binding peptides. Second, the cortactin SH3 domain-binding
peptides show a strict preference for lysine over arginine at the 5 position (Fig. 2D). We have examined the contribution of the CortBP1
ppI motif to interaction with cortactin by mutational analysis.
Mutation of proline 948 and proline 950 to alanine within the ppI motif
(e.g., ...KPA948VA950PKP...) reduced the
ability of CortBP1 to bind the cortactin SH3 domain in two-hybrid
interaction analysis and with endogenous cortactin in in vitro GST
pull-down experiments (data not shown). While these results underscore
the importance of the CortBP1 ppI motif in binding the cortactin SH3
domain, we cannot rule out the contribution of other CortBP1 sequences
in mediating the stable interactions with the cortactin SH3 domain.
The C-terminal 67 amino acids of CortBP1 display extensive similarity
to SAM domains, recently identified protein modules present in diverse
eukaryotic organisms from yeasts to humans (60).
SAM-containing proteins have been implicated in developmental regulation and signal transduction (60). For example,
SAM-containing proteins are essential for pheromone-induced sexual
differentiation in yeast (Byr2p, Ste11p, and Ste4p
[16]) and for regulating anterior-posterior patterning
in Drosophila oocytes (polyhomeotic protein and Bicaudal-C
[18, 46]). Two yeast SAM domain-containing proteins,
Boi1p and Boi2p, are associated with cytoskeleton and play an important
role in the maintenance of cell polarity during bud formation
(6). While the molecular function of SAM domains remains
largely unclear, recent studies of several SAM-containing proteins
suggest a possible role of SAM domains in mediating protein-protein interactions (3, 48, 55, 64). Given the apparent association of CortBP1 with cortactin-F-actin complexes, it will be
interesting to further investigate whether the CortBP1 SAM domain is
responsible for recruiting other signaling proteins to the dynamic
cortical cytoskeleton in growth cones.
In contrast to the cortactin gene, which is expressed in a wide variety
of tissues, the expression pattern of the CortBP1 gene appears
restricted. Northern blot analysis has shown that the major species of
CortBP1 transcript (~8 kb) is present exclusively in brain tissue and
a less abundant species (~9.5 kb) is present in brain, kidney, lung,
and liver tissues. Whereas the CortBP1 protein is readily detected in
brain tissues by Western blot analysis, we have failed to detect p180
CortBP1 in kidney, lung, and liver tissues. The difficulty of detecting
the CortBP1 protein in these tissues may be due to the lower
sensitivity of the Western blot analysis. The restricted expression
pattern of CortBP1 suggests that the cortactin-CortBP1 interaction may
have physiological significance in neurons and that in other cell types
cortactin may interact with either CortBP1-like protein(s) or another
tissue-specific binding partner(s).
Previous studies have shown that cortactin displays an intense staining
within lamellipodia as well as a punctate staining within the cytoplasm
in adherent cells cultured in the presence of serum (77,
78). Recent studies from our laboratory (73) have
shown that the distribution of cortactin between the cortical cytoskeleton and cytoplasmic structures is regulated. Sequestration of
cortactin to the cytoplasmic pool increases upon serum starvation. Translocation of cortactin into lamellipodia and membrane ruffles is
dramatically enhanced by activation of Rac1, a small GTP-binding protein of the Rho family. The cortical cytoskeleton-targeting signal
is located within the N-terminal half of cortactin, whereas sequences
within the C-terminal half appear to be dispensable for cortical actin
localization (74). Based on these data and the documented
function of SH3 domains in recruiting their ligands to certain
subcellular compartments (15), we propose that the cortactin
SH3 domain plays a role in targeting its binding partner(s) to the
cortical cytoskeleton. In support of this, we have shown here that a
significant portion of overexpressed CortBP1 colocalizes with cortactin
and F-actin in lamellipodia and membrane ruffles of cultured murine
fibroblast cells. The colocalization of CortBP1 with cortactin and
F-actin was also observed in podosome-like structures in 10T1/2 cells
overexpressing c-Src. These observations strongly suggest that
cortactin mediates formation of multiprotein complexes within the
cortical cytoskeleton, by the concomitant interaction with cortical
F-actin via its N-terminal repeats and with other cellular proteins via
the SH3 domain at its C terminus. Thus, cortactin would serve as a
cortical actin-specific docking protein for binding partners such as
CortBP1.
We have further shown in this study that endogenous cortactin and
CortBP1 colocalize within the cortical F-actin-containing subcellular
compartment in primary cultures of differentiating rat neurons.
Indirect immunofluorescence analysis suggests that both cortactin and
CortBP1 are components of growth cones in cultured neurons isolated
from embryonic 18-day rat hippocampus. These cells, when placed in
culture, extend neurites mimicking their developmental morphology in
vivo (22). The immunostaining of CortBP1 within growth cones
appeared to be specific, since preimmune serum and antigen-blocked
antibody failed to stain growth cones. The cortactin staining is
essentially confined to growth cones, similar to the staining pattern
of cortactin observed within growth cones of cultured
Xenopus spinal cord neurons (57). Both CortBP1 staining and cortactin staining in growth cones of rat hippocampal neurons are primarily localized within the central portion of growth
cones, very similar to the previously described staining pattern of
F-actin in these cells (31). Additionally, costaining experiments support the colocalization of cortactin and F-actin in
growth cones of the rat hippocampal neurons (data not shown). Previous
studies have suggested that the F-actin remodeling within neuronal
growth cones, in response to extracellular attraction or repulsion
cues, plays an important role in regulating directional neurite
extension (7, 45). Many proteins, including members of the
Src family of tyrosine kinases (36, 47); actin-binding proteins such as profilin (26), gelsolin (68),
myosin-V (72), and neurabin (52); and
membrane-associated protein GAP-43 (2), have been identified
as components of growth cones. Of note, the recently identified neural
tissue-specific F-actin-binding protein neurabin has been implicated in
neurite formation (52). The localization of cortactin and
CortBP1 within growth cones, together with the brain-specific
expression of CortBP1, suggests that the cortactin-CortBP1 interaction
may also be involved in signaling pathways associated with the
formation and migration of growth cones during neurite outgrowth.
A database search for CortBP1 homologs in other organisms reveals two
human brain cDNA fragments in the expressed sequence tag database
(accession no. m86079 and h41098 [1]) and one human
DNA segment in the sequence-tagged site database (accession no. z51760
[21]). Both display high DNA sequence identity (81, 90, and 88%, respectively) to rat CortBP1 cDNA. The similarity between
rat CortBP1 and the predicted open reading frames of these DNA
sequences spans the N-terminal region (amino acids 294 to 405, 27 to
171, and 1 to 57, respectively). The existence of a putative human
CortBP1 homolog is an indication of the conservation of CortBP1
function in other organisms and an involvement of CortBP1 in common
biological processes in diverse organisms.
 |
ACKNOWLEDGMENTS |
We thank G. Banker and H. Asmussen for in vitro-cultured rat
hippocampal neurons, S. J. Parsons for 10T1/2neo and 5Hd47 cells, A. A. Lanahan for pPC86 and pPC97 vectors and the rat hippocampus cDNA library in pPC86, A. Hall for the pRK5myc vector, J. S. Morrow for the pcDNA3Flag2AB vector, and M. T. Harte for the
GST-FAKcte expression vector. We also thank M. E. Cox for helpful
discussions.
This work was supported by grants CA29243 and CA40042 from the DHHS-NCI
and grant 4491 from the Council for Tobacco Research, Inc., to J. T. Parsons; S. A. Weed is supported by NIH postdoctoral fellowship
1 F32 CA75695-01; W.-C. Xiong is supported by NIH NRSA fellowship
NS09918.
 |
ADDENDUM IN PROOF |
CortBP1 contains a single PDZ domain (amino acids 38 to 133) that
has sequence similarity to the PDZ domains of PSD95, Disc large-1, and
Z0-1.
 |
FOOTNOTES |
*
Corresponding author. Mailing address: Department of
Microbiology, Box 441, Health Science Center, University of Virginia, Charlottesville, VA 22908. Phone: (804) 924-5395. Fax: (804) 982-1071. E-mail: jtp{at}virginia.edu.
Present address: c/o CMHA (NF Division), St. John's, Newfoundland
A1C 5X3, Canada.
 |
REFERENCES |
| 1.
|
Adams, M. D.,
M. Dubnick,
A. R. Kerlavage,
R. Moreno,
J. M. Kelley,
T. R. Utterback,
J. W. Nagle,
C. Fields, and J. C. Venter.
1992.
Sequence identification of 2,375 human brain genes.
Nature (London)
355:632-634[Medline].
|
| 2.
|
Aigner, L., and P. Caroni.
1995.
Absence of persistent spreading, branching, and adhesion in GAP-43-depleted growth cones.
J. Cell Biol.
128:647-660[Abstract/Free Full Text].
|
| 3.
|
Barr, M. M.,
H. Tu,
L. V. Aelst, and M. Wigler.
1996.
Identification of Ste4 as a potential regulator of Byr2 in the sexual response pathway of Schizosaccharomyces pombe.
Mol. Cell. Biol.
16:5597-5603[Abstract].
|
| 4.
|
Bartel, P. L., and S. Fields.
1995.
Analyzing protein-protein interactions using two-hybrid system.
Methods Enzymol.
254:241-263[Medline].
|
| 5.
|
Bartlett, W. P., and G. A. Banker.
1984.
An electron microscopic study of the development of axons and dendrites by hippocampal neurons in culture. I. Cells which develop without intercellular contacts.
J. Neurosci.
4:1944-1953[Abstract].
|
| 6.
|
Bender, L.,
H. S. Lo,
H. Lee,
V. Kokojan,
J. Peterson, and A. Bender.
1996.
Associations among PH and SH3 domain-containing proteins and Rho-type GTPases in yeast.
J. Cell Biol.
133:879-894[Abstract/Free Full Text].
|
| 7.
|
Bentley, D., and T. P. O'Connor.
1994.
Cytoskeleton events in growth cone steering.
Curr. Opin. Neurobiol.
4:43-48[Medline].
|
| 8.
|
Bretscher, A.
1991.
Microfilament structure and function in the cortical cytoskeleton.
Annu. Rev. Cell Biol.
7:337-374.
|
| 9.
|
Button, E.,
C. Shapland, and D. Lawson.
1995.
Actin, its associated proteins and metastasis.
Cell Motil. Cytoskelet.
30:247-251[Medline].
|
| 10.
|
Cao, L. G., and Y. L. Wang.
1990.
Mechanism of the formation of contractile ring in dividing culture animal cells.
J. Cell Biol.
110:1089-1095[Abstract/Free Full Text].
|
| 11.
|
Chang, J.-H.,
S. Gill,
J. Settleman, and S. J. Parsons.
1995.
c-Src regulates the simultaneous rearrangement of actin cytoskeleton, p190RhoGAP, and p120RasGAP following epidermal growth factor stimulation.
J. Cell Biol.
130:355-368[Abstract/Free Full Text].
|
| 12.
|
Chen, W.-T.,
J.-M. Chen,
S. J. Parsons, and J. T. Parsons.
1985.
Local degradation of fibronectin at sites of expression of the transforming gene product pp60src.
Nature (London)
316:156-158[Medline].
|
| 13.
|
Chevray, P. M., and D. Nathans.
1992.
Protein interaction cloning in yeast: identification of mammalian proteins that react with the leucine zipper of Jun.
Proc. Natl. Acad. Sci. USA
89:5789-5793[Abstract/Free Full Text].
|
| 14.
|
Clerc, P., and P. J. Sansonetti.
1987.
Entry of Shigella flexneri into HeLa cells: evidence for directed phagocytosis involving actin polymerization and myosin accumulation.
Infect. Immun.
55:2681-2688[Abstract/Free Full Text].
|
| 15.
|
Cohen, G. B.,
R. Ren, and D. Baltimore.
1995.
Modular binding domains in signal transduction proteins.
Cell
80:237-248[Medline].
|
| 16.
|
Cook, S., and F. McCormick.
1994.
Ras blooms on sterile ground.
Science
369:361-362.
|
| 17.
|
Dai, Z., and A. M. Pendergast.
1995.
Abi2, a novel SH3-containing protein, interacts with the c-Ab1 tyrosine kinase and modulates c-Ab1 transforming activity.
Genes Dev.
9:2526-2528.
|
| 18.
|
DeCamillis, M.,
N. Cheng,
D. Pierre, and H. W. Brock.
1992.
The polyhomeotic gene of Drosophila encodes a chromatin protein that shares polytene chromosome-binding sites with Polycomb.
Genes Dev.
6:223-232[Abstract/Free Full Text].
|
| 19.
|
Dehio, C.,
M.-C. Prevost, and P. J. Sansonetti.
1995.
Invasion of epithelial cells by Shigella flexneri induces tyrosine phosphorylation of cortactin by a pp60c-src-mediated signaling pathway.
EMBO J.
14:2471-2482[Medline].
|
| 20.
|
Devarajan, P.,
P. R. Stabach,
M. A. Dematteis, and J. S. Morrow.
1997.
Na, K-ATPase transport from endoplasmic reticulum to Golgi requires the Golgi spectrin-ankyrin G119 skeleton in Madin-Darby canine kidney cells.
Proc. Natl. Acad. Sci. USA
94:10711-10716[Abstract/Free Full Text].
|
| 21.
|
Dib, C.,
S. Faure,
C. Fizames,
D. Samson,
N. Drouot,
A. Vignal,
P. Millasseau,
S. Marc,
J. Hazan,
E. Seboun,
M. Lathrop,
G. Gyapay,
J. Morissette, and J. Weissenbach.
1996.
A comprehensive genetic map of the human genome based on 5,264 microsatellites.
Nature (London)
380:152-154[Medline].
|
| 22.
|
Dotti, C. G.,
C. A. Sullivan, and G. A. Banker.
1988.
The establishment of polarity by hippocampal neurons in culture.
J. Neurosci.
8:1454-1468[Abstract].
|
| 23.
|
Downing, J. R., and A. B. Reynolds.
1991.
PDGF, CSF-1 and EGF induce tyrosine phosphorylation of p120, a pp60src transformation-associated substrate.
Oncogene
6:607-613[Medline].
|
| 24.
|
Drubin, D. G.,
J. Mulholland,
Z. Zhu, and D. Botstein.
1990.
Homology of a yeast actin-binding protein to signal transduction proteins and myosin-1.
Nature (London)
343:288-290[Medline].
|
| 25.
|
Durieu-Trautmann, O.,
N. Chaverot,
S. Cazaubon,
A. D. Strosberg, and P.-O. Couraud.
1994.
Intercellular adhesion molecule 1 activation induces tyrosine phosphorylation of the cytoskeleton-associated protein cortactin in brain microvessel endothelial cells.
J. Biol. Chem.
269:12536-12540[Abstract/Free Full Text].
|
| 26.
|
Faivre-Sarrailh, C.,
J. Y. Lena,
L. Had,
M. Vignes, and U. Lindberg.
1993.
Localization of profilin at presynaptic sites in the cerebellar cortex; implication for the regulation of the actin-polymerization state during axonal elongation and synaptogenesis.
J. Neurocytol.
22:1060-1072[Medline].
|
| 27.
|
Feng, S.,
J. K. Chen,
H. Yu,
J. A. Simon, and S. L. Schreiber.
1994.
Two binding orientations for peptides to the Src SH3 domain: development of a general model for SH3-ligand interactions.
Science
266:1241-1247[Abstract/Free Full Text].
|
| 28.
|
Fields, S., and O. Song.
1989.
A novel genetic system to detect protein-protein interactions.
Nature (London)
340:245-246[Medline].
|
| 29.
|
Gietz, R. D., and R. H. Schiestl.
1991.
Applications of high efficiency lithium acetate transformation of intact yeast cells using single-stranded nucleic acids as carrier.
Yeast
7:253-263[Medline].
|
| 30.
|
Goodman, C. S.
1996.
Mechanisms and molecules that control growth cone guidance.
Annu. Rev. Neurosci.
19:341-377[Medline].
|
| 31.
|
Goslin, K.,
E. Birgbauer,
G. Banker, and F. Solomon.
1989.
The role of cytoskeleton in organizing growth cones: a microfilament-associated growth cone component depends upon microtubules for its localization.
J. Cell Biol.
109:1621-1631[Abstract/Free Full Text].
|
| 32.
|
Greene, L. A.,
J. M. Aletta,
A. Rukenstein, and S. H. Green.
1987.
PC12 pheochromocytoma cells: culture, nerve growth factor treatment, and experimental exploitation.
Methods Enzymol.
147:207-216[Medline].
|
| 33.
|
Hall, A.
1998.
Rho GTPases and the actin cytoskeleton.
Science
279:509-514[Abstract/Free Full Text].
|
| 34.
|
Harper, J. W.,
G. R. Adami,
N. Wei,
K. Keyomarsi, and S. J. Elledge.
1993.
The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases.
Cell
75:805-816[Medline].
|
| 35.
|
Harte, M. T.,
J. D. Hildebrand,
M. R. Burnham,
A. H. Bouton, and J. T. Parsons.
1996.
p130Cas, a substrate associated with v-Src and v-Crk, localizes to focal adhesions and binds to focal adhesion kinase.
J. Biol. Chem.
271:13649-13655[Abstract/Free Full Text].
|
| 36.
|
Helmke, S., and K. H. Pfenninger.
1995.
Growth cone enrichment and cytoskeletal association of non-receptor tyrosine kinases.
Cell Motil. Cytoskelet.
30:194-207[Medline].
|
| 37.
|
Hildebrand, J. D.,
J. M. Taylor, and J. T. Parsons.
1996.
An SH3 domain-containing GTPase-activating protein for Rho and Cdc42 associates with focal adhesion kinase.
Mol. Cell. Biol.
16:3169-3178[Abstract].
|
| 38.
|
Hitt, A., and E. J. Luna.
1994.
Membrane interactions with the actin cytoskeleton.
Curr. Opin. Cell Biol.
6:120-130[Medline].
|
| 39.
|
Kanner, S. B.,
A. B. Reynolds,
R. R. Vines, and J. T. Parsons.
1990.
Monoclonal antibodies to individual tyrosine-phosphorylated protein substrates of oncogene-encoded tyrosine kinases.
Proc. Natl. Acad. Sci. USA
87:3328-3332[Abstract/Free Full Text].
|
| 40.
|
Kitamura, D.,
H. Kaneko,
Y. Miyagoe,
T. Ariyasu, and T. Watanabe.
1989.
Isolation and characterization of a novel human gene expressed specifically in the cells of hematopoietic lineage.
Nucleic Acids Res.
17:9367-9379.
|
| 41.
|
Kitamura, D.,
H. Kaneko,
I. Taniuchi,
K. Akagi,
K.-I. Yamamura, and T. Watanabe.
1995.
Molecular cloning and characterization of mouse HS1.
Biochem. Biophys. Res. Commun.
208:1137-1146[Medline].
|
| 42.
|
Kozak, M.
1989.
The scanning model for translation: an update.
J. Cell Biol.
108:229-241[Abstract/Free Full Text].
|
| 43.
|
Larabell, C. A.
1995.
Cortical cytoskeleton of the Xenopus oocyte, egg, and early embryo.
Curr. Top. Dev. Biol.
31:433-453[Medline].
|
| 44.
|
Lehmann, J. M.,
G. Riethmuller, and J. P. Johnson.
1990.
NCK, a melanoma cDNA encoding a cytoplasmic protein consisting of the src homology units SH2 and SH3.
Nucleic Acids Res.
18:1048[Free Full Text].
|
| 45.
|
Lin, C.-H.,
C. Thompson, and P. Forscher.
1994.
Cytoskeletal reorganization underlying growth cone motility.
Curr. Opin. Neurobiol.
4:640-647[Medline].
|
| 46.
|
Mahone, M.,
E. E. Saffman, and P. F. Lasko.
1995.
Localized Bicaudal-C RNA encodes a protein containing a KH domain, the RNA binding motif of FMR1.
EMBO J.
14:2043-2055[Medline].
|
| 47.
|
Maness, P. F.,
M. Aubry,
C. G. Shores,
L. Frame, and K. H. Pfenninger.
1988.
c-Src gene product in developing rat brain is enriched in nerve growth cone membranes.
Proc. Natl. Acad. Sci. USA
85:5001-5005[Abstract/Free Full Text].
|
| 48.
|
Marcus, S.,
A. Polverino,
M. Barr, and M. Wigler.
1994.
Complexes between STE5 and components of the pheromone-responsive mitogen-activated protein kinase module.
Proc. Natl. Acad. Sci. USA
91:7762-7766[Abstract/Free Full Text].
|
| 49.
|
Mayer, B. J., and M. J. Eck.
1995.
Minding your p's and q's.
Curr. Biol.
5:364-367[Medline].
|
| 50.
|
Meredith, S. D.,
P. A. Levine,
J. A. Burns,
M. J. Gaffey,
J. C. Boyd,
L. M. Weiss,
N. L. Erickson, and M. E. Williams.
1995.
Chromosome 11q13 amplification in head and neck squamous cell carcinoma.
Arch. Otolaryngol. Head Neck Surg.
121:790-794.
|
| 51.
|
Miglarese, M. R.,
J. Mannion-Henderson,
H. Wu,
J. T. Parsons, and T. P. Bender.
1994.
The protein tyrosine kinase substrate cortactin is differentially expressed in murine B lymphoid tumors.
Oncogene
9:1989-1998[Medline].
|
| 52.
|
Nakanishi, H.,
H. Obaishi,
A. Satoh,
M. Wada,
K. Mandai,
K. Satoh,
H. Nishioka,
Y. Matsuura,
A. Mizoguchi, and Y. Takai.
1997.
Neurabin: a novel neural tissue-specific actin filament-binding protein involved in neurite formation.
J. Cell Biol.
139:951-961[Abstract/Free Full Text].
|
| 53.
|
Okamura, H., and M. D. Resh.
1995.
p80/85 cortactin associates with the Src SH2 domain and colocalizes with v-Src in transformed cells.
J. Biol. Chem.
270:26613-26618[Abstract/Free Full Text].
|
| 54.
|
Olson, M. F.,
N. G. Pasteris,
J. L. Gorski, and A. Hall.
1996.
Faciogenital dysplasia protein (FGD1) and Vav, two related proteins required for normal embryonic development, are upstream regulators of Rho GTPases.
Curr. Biol.
6:1628-1633[Medline].
|
| 55.
|
Pandey, A.,
H. Duan, and V. M. Dixit.
1995.
Characterization of a novel Src-like adaptor protein that associates with the Eck receptor tyrosine kinase.
J. Biol. Chem.
270:19201-19204[Abstract/Free Full Text].
|
| 56.
|
Patel, A. M.,
L. S. Incognito,
G. L. Schechter,
W. J. Wasilenko, and K. D. Somers.
1996.
Amplification and expression of EMS-1 (cortactin) in head and neck squamous cell carcinoma cell lines.
Oncogene
12:31-35[Medline].
|
| 57.
|
Peng, H. B.,
H. Xie, and Z. Dai.
1997.
Association of cortactin with developing neuromuscular specializations.
J. Neurocytol.
26:637-650[Medline].
|
| 58.
|
Ponting, C. P.
1995.
SAM: a novel motif in yeast sterile and Drosophila polyhomeotic proteins.
Protein Sci.
4:1928-1930[Medline].
|
| 59.
|
Ridley, A. J.
1994.
Membrane ruffling and signal transduction.
Bioessays
16:321-327[Medline].
|
| 60.
|
Schultz, J.,
C. P. Ponting,
K. Hofmann, and P. Bork.
1997.
SAM as a protein interaction domain involved in developmental regulation.
Protein Sci.
6:249-253[Medline].
|
| 61.
|
Schuuring, E.,
E. Verhoeven,
W. J. Mooi, and R. J. A. M. Michalides.
1992.
Identification and cloning of two overexpressed genes, U21B31/PRAD1 and EMS1, within the amplified chromosome 11q13 region in human carcinomas.
Oncogene
7:355-361[Medline].
|
| 62.
|
Schuuring, E.,
E. Verhoeven,
H. V. Tinteren,
J. L. Peterse,
B. Nunnink,
F. B. J. M. Thunnissen,
P. Devilee,
C. J. Cornelisse,
M. J. V. D. Vijver,
W. J. Mooi, and R. J. A. M. Michalides.
1992.
Amplification of genes within the chromosome 11q13 region is indicative of poor prognosis in patients with operable breast cancer.
Cancer Res.
52:5229-5234[Abstract/Free Full Text].
|
| 63.
|
Schuuring, E.,
E. Verhoeven,
S. Litvinov, and R. J. A. M. Michalides.
1993.
The product of the EMS1 gene, amplified and overexpressed in human carcinomas, is homologous to a v-src substrate and is located in cell-substratum contact sites.
Mol. Cell. Biol.
13:2891-2898[Abstract/Free Full Text].
|
| 64.
|
Serra-Pages, C.,
N. L. Kedersha,
L. Fazikas,
Q. Medley,
A. Debant, and M. Streuli.
1995.
The LAR transmembrane protein tyrosine phosphatase and a coiled-coil LAR-interacting protein co-localize at focal adhesions.
EMBO J.
14:2827-2838[Medline].
|
| 65.
|
Smith, D. B., and K. S. Johnson.
1988.
Single-step purification of polypeptides expressed in Escherichia coli as fusions with glutathione S-transferase.
Gene
67:31-40[Medline].
|
| 66.
|
Sparks, A. B.,
J. E. Rider,
N. G. Hoffman,
D. M. Fowlkes,
L. A. Quilliam, and B. K. Kay.
1996.
Distinct ligand preferences of Src homology 3 domains from Src, Yes, Ab1, Cortactin, p53bp2, PLC , Crk, and Grb2.
Proc. Natl. Acad. Sci. USA
93:1540-1544[Abstract/Free Full Text].
|
| 67.
|
Stossel, T. P.
1993.
On the crawling of animal cells.
Science
260:1086-1094[Abstract/Free Full Text].
|
| 68.
|
Tanaka, J.,
M. Kira, and K. Sobue.
1993.
Gelsolin is localized in neuronal growth cones.
Dev. Brain Res.
76:268-271[Medline].
|
| 69.
|
Tanaka, M.,
R. Gupta, and B. J. Mayer.
1995.
Differential inhibition of signaling pathways by dominant-negative SH2/SH3 adaptor protein.
Mol. Cell. Biol.
15:6829-6837[Abstract].
|
| 70.
|
Taniuchi, I.,
D. Kitamura,
Y. Maekawa,
T. Fukuda,
H. Kishi, and T. Watanabe.
1995.
Antigen-receptor induced clonal expansion and deletion of lymphocytes are impaired in mice lacking HS1 protein, a substrate of the antigen-receptor-coupled tyrosine kinases.
EMBO J.
14:3664-3678[Medline].
|
| 71.
|
Tarone, G.,
D. Cirillo,
F. G. Giancotti,
P. M. Comoglio, and P. C. Marchisio.
1985.
Rous sarcoma virus-transformed fibroblasts adhere primarily at discrete protrusions of the ventral membrane celled podosomes.
Exp. Cell Res.
159:141-157[Medline].
|
| 72.
|
Wang, F.-S.,
J. S. Wolenski,
R. E. Cheney,
M. S. Mooseker, and D. G. Jay.
1996.
Function of myosin-V in filopodial extension of neuronal growth cones.
Science
273:660-663[Abstract].
|
| 73.
|
Weed, S. A.,
Y. Du, and J. T. Parsons.
1998.
Translocation of cortactin to the cell periphery is mediated by the small GTPase Rac1.
J. Cell Sci.
111:2433-2443[Abstract].
|
| 74.
| Weed, S. A., Y. Du, and J. T. Parsons.
Unpublished data.
|
| 75.
|
Wilusz, J.,
S. M. Pettine, and T. Shenk.
1989.
Functional analysis of point mutations in the AAUAAA motif of the SV40 late polyadenylation signal.
Nucleic Acids Res.
17:3899-3908[Abstract/Free Full Text].
|
| 76.
|
Wong, S.,
A. B. Reynolds, and J. Papkoff.
1992.
Platelet activation leads to increased c-src kinase activity and association of c-src with an 85-kDa tyrosine phosphoprotein.
Oncogene
7:2407-2415[Medline].
|
| 77.
|
Wu, H.,
A. B. Reynolds,
S. B. Kanner,
R. R. Vines, and J. T. Parsons.
1991.
Identification and characterization of a novel cytoskeleton-associated pp60src substrate.
Mol. Cell. Biol.
11:5113-5124[Abstract/Free Full Text].
|
| 78.
|
Wu, H., and J. T. Parsons.
1993.
Cortactin, an 80/85-kilodalton pp60src substrate, is a filamentous actin-binding protein enriched in the cell cortex.
J. Cell Biol.
120:1417-1426[Abstract/Free Full Text].
|
| 79.
|
Zhan, X.,
X. Hu,
B. Hampton,
W. H. Burgess,
R. Friesel, and T. Maciag.
1993.
Murine cortactin is phosphorylated in response to fibroblast growth factor-1 on tyrosine residues late in the G1 phase of the BALB/c 3T3 cell cycle.
J. Biol. Chem.
268:24427-24431[Abstract/Free Full Text].
|
Molecular and Cellular Biology, October 1998, p. 5838-5851, Vol. 18, No. 10
0270-7306/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Lai, F. P.L., Szczodrak, M., Oelkers, J. M., Ladwein, M., Acconcia, F., Benesch, S., Auinger, S., Faix, J., Small, J. V., Polo, S., Stradal, T. E.B., Rottner, K.
(2009). Cortactin Promotes Migration and Platelet-derived Growth Factor-induced Actin Reorganization by Signaling to Rho-GTPases. Mol. Biol. Cell
20: 3209-3223
[Abstract]
[Full Text]
-
Haeckel, A., Ahuja, R., Gundelfinger, E. D., Qualmann, B., Kessels, M. M.
(2008). The Actin-Binding Protein Abp1 Controls Dendritic Spine Morphology and Is Important for Spine Head and Synapse Formation. J. Neurosci.
28: 10031-10044
[Abstract]
[Full Text]
-
Jia, L., Uekita, T., Sakai, R.
(2008). Hyperphosphorylated Cortactin in Cancer Cells Plays an Inhibitory Role in Cell Motility. Mol Cancer Res
6: 654-662
[Abstract]
[Full Text]
-
Hung, A. Y., Futai, K., Sala, C., Valtschanoff, J. G., Ryu, J., Woodworth, M. A., Kidd, F. L., Sung, C. C., Miyakawa, T., Bear, M. F., Weinberg, R. J., Sheng, M.
(2008). Smaller Dendritic Spines, Weaker Synaptic Transmission, but Enhanced Spatial Learning in Mice Lacking Shank1. J. Neurosci.
28: 1697-1708
[Abstract]
[Full Text]
-
Usatyuk, P. V., Romer, L. H., He, D., Parinandi, N. L., Kleinberg, M. E., Zhan, S., Jacobson, J. R., Dudek, S. M., Pendyala, S., Garcia, J. G. N., Natarajan, V.
(2007). Regulation of Hyperoxia-induced NADPH Oxidase Activation in Human Lung Endothelial Cells by the Actin Cytoskeleton and Cortactin. J. Biol. Chem.
282: 23284-23295
[Abstract]
[Full Text]
-
Lamprecht, G., Seidler, U.
(2006). The emerging role of PDZ adapter proteins for regulation of intestinal ion transport. Am. J. Physiol. Gastrointest. Liver Physiol.
291: G766-G777
[Abstract]
[Full Text]
-
Cosen-Binker, L. I., Kapus, A.
(2006). Cortactin: The Gray Eminence of the Cytoskeleton.. Physiology
21: 352-361
[Abstract]
[Full Text]
-
Kuriu, T., Inoue, A., Bito, H., Sobue, K., Okabe, S.
(2006). Differential control of postsynaptic density scaffolds via actin-dependent and -independent mechanisms.. J. Neurosci.
26: 7693-7706
[Abstract]
[Full Text]
-
Wendholt, D., Spilker, C., Schmitt, A., Dolnik, A., Smalla, K.-H., Proepper, C., Bockmann, J., Sobue, K., Gundelfinger, E. D., Kreutz, M. R., Boeckers, T. M.
(2006). ProSAP-interacting Protein 1 (ProSAPiP1), a Novel Protein of the Postsynaptic Density That Links the Spine-associated Rap-Gap (SPAR) to the Scaffolding Protein ProSAP2/Shank3. J. Biol. Chem.
281: 13805-13816
[Abstract]
[Full Text]
-
McWilliams, R. R., Breusegem, S. Y., Brodsky, K. F., Kim, E., Levi, M., Doctor, R. B.
(2005). Shank2E binds NaPi cotransporter at the apical membrane of proximal tubule cells. Am. J. Physiol. Cell Physiol.
289: C1042-C1051
[Abstract]
[Full Text]
-
Gray, N. W., Kruchten, A. E., Chen, J., McNiven, M. A.
(2005). A dynamin-3 spliced variant modulates the actin/cortactin-dependent morphogenesis of dendritic spines. J. Cell Sci.
118: 1279-1290
[Abstract]
[Full Text]
-
Zhu, J., Zhou, K., Hao, J.-J., Liu, J., Smith, N., Zhan, X.
(2005). Regulation of cortactin/dynamin interaction by actin polymerization during the fission of clathrin-coated pits. J. Cell Sci.
118: 807-817
[Abstract]
[Full Text]
-
Quitsch, A., Berhorster, K., Liew, C. W., Richter, D., Kreienkamp, H.-J.
(2005). Postsynaptic Shank Antagonizes Dendrite Branching Induced by the Leucine-Rich Repeat Protein Densin-180. J. Neurosci.
25: 479-487
[Abstract]
[Full Text]
-
Sauvonnet, N., Dujeancourt, A., Dautry-Varsat, A.
(2005). Cortactin and dynamin are required for the clathrin-independent endocytosis of {gamma}c cytokine receptor. JCB
168: 155-163
[Abstract]
[Full Text]
-
Schuetz, G., Rosario, M., Grimm, J., Boeckers, T. M., Gundelfinger, E. D., Birchmeier, W.
(2004). The neuronal scaffold protein Shank3 mediates signaling and biological function of the receptor tyrosine kinase Ret in epithelial cells. JCB
167: 945-952
[Abstract]
[Full Text]
-
Knoll, B., Drescher, U.
(2004). Src Family Kinases Are Involved in EphA Receptor-Mediated Retinal Axon Guidance. J. Neurosci.
24: 6248-6257
[Abstract]
[Full Text]
-
Martinez-Quiles, N., Ho, H.-Y. H., Kirschner, M. W., Ramesh, N., Geha, R. S.
(2004). Erk/Src Phosphorylation of Cortactin Acts as a Switch On-Switch Off Mechanism That Controls Its Ability To Activate N-WASP. Mol. Cell. Biol.
24: 5269-5280
[Abstract]
[Full Text]
-
Dudek, S. M., Jacobson, J. R., Chiang, E. T., Birukov, K. G., Wang, P., Zhan, X., Garcia, J. G. N.
(2004). Pulmonary Endothelial Cell Barrier Enhancement by Sphingosine 1-Phosphate: ROLES FOR CORTACTIN AND MYOSIN LIGHT CHAIN KINASE. J. Biol. Chem.
279: 24692-24700
[Abstract]
[Full Text]
-
Lua, B. L., Low, B. C.
(2004). BPGAP1 Interacts with Cortactin and Facilitates Its Translocation to Cell Periphery for Enhanced Cell Migration. Mol. Biol. Cell
15: 2873-2883
[Abstract]
[Full Text]
-
Qualmann, B., Boeckers, T. M., Jeromin, M., Gundelfinger, E. D., Kessels, M. M.
(2004). Linkage of the Actin Cytoskeleton to the Postsynaptic Density via Direct Interactions of Abp1 with the ProSAP/Shank Family. J. Neurosci.
24: 2481-2495
[Abstract]
[Full Text]
-
Bresler, T., Shapira, M., Boeckers, T., Dresbach, T., Futter, M., Garner, C. C., Rosenblum, K., Gundelfinger, E. D., Ziv, N. E.
(2004). Postsynaptic Density Assembly Is Fundamentally Different from Presynaptic Active Zone Assembly. J. Neurosci.
24: 1507-1520
[Abstract]
[Full Text]
-
Parker, M. J., Zhao, S., Bredt, D. S., Sanes, J. R., Feng, G.
(2004). PSD93 Regulates Synaptic Stability at Neuronal Cholinergic Synapses. J. Neurosci.
24: 378-388
[Abstract]
[Full Text]
-
Hering, H., Sheng, M.
(2003). Activity-Dependent Redistribution and Essential Role of Cortactin in Dendritic Spine Morphogenesis. J. Neurosci.
23: 11759-11769
[Abstract]
[Full Text]
-
Hou, P., Estrada, L., Kinley, A. W., Parsons, J. T., Vojtek, A. B., Gorski, J. L.
(2003). Fgd1, the Cdc42 GEF responsible for Faciogenital Dysplasia, directly interacts with cortactin and mAbp1 to modulate cell shape. Hum Mol Genet
12: 1981-1993
[Abstract]
[Full Text]
-
Head, J. A., Jiang, D., Li, M., Zorn, L. J., Schaefer, E. M., Parsons, J. T., Weed, S. A.
(2003). Cortactin Tyrosine Phosphorylation Requires Rac1 Activity and Association with the Cortical Actin Cytoskeleton. Mol. Biol. Cell
14: 3216-3229
[Abstract]
[Full Text]
-
Sala, C., Futai, K., Yamamoto, K., Worley, P. F., Hayashi, Y., Sheng, M.
(2003). Inhibition of Dendritic Spine Morphogenesis and Synaptic Transmission by Activity-Inducible Protein Homer1a. J. Neurosci.
23: 6327-6337
[Abstract]
[Full Text]
-
Martinez, M. C., Ochiishi, T., Majewski, M., Kosik, K. S.
(2003). Dual regulation of neuronal morphogenesis by a {delta}-catenin-cortactin complex and Rho. JCB
162: 99-111
[Abstract]
[Full Text]
-
Lynch, D. K., Winata, S. C., Lyons, R. J., Hughes, W. E., Lehrbach, G. M., Wasinger, V., Corthals, G., Cordwell, S., Daly, R. J.
(2003). A Cortactin-CD2-associated Protein (CD2AP) Complex Provides a Novel Link between Epidermal Growth Factor Receptor Endocytosis and the Actin Cytoskeleton. J. Biol. Chem.
278: 21805-21813
[Abstract]
[Full Text]
-
Redecker, P., Kreutz, M. R., Bockmann, J., Gundelfinger, E. D., Boeckers, T. M.
(2003). Brain Synaptic Junctional Proteins at the Acrosome of Rat Testicular Germ Cells. J. Histochem. Cytochem.
51: 809-819
[Abstract]
[Full Text]
-
Park, E., Na, M., Choi, J., Kim, S., Lee, J.-R., Yoon, J., Park, D., Sheng, M., Kim, E.
(2003). The Shank Family of Postsynaptic Density Proteins Interacts with and Promotes Synaptic Accumulation of the {beta}PIX Guanine Nucleotide Exchange Factor for Rac1 and Cdc42. J. Biol. Chem.
278: 19220-19229
[Abstract]
[Full Text]
-
Usui, S., Konno, D., Hori, K., Maruoka, H., Okabe, S., Fujikado, T., Tano, Y., Sobue, K.
(2003). Synaptic Targeting of PSD-Zip45 (Homer 1c) and Its Involvement in the Synaptic Accumulation of F-actin. J. Biol. Chem.
278: 10619-10628
[Abstract]
[Full Text]
-
Hall, R. A., Lefkowitz, R. J.
(2002). Regulation of G Protein-Coupled Receptor Signaling by Scaffold Proteins. Circ. Res.
91: 672-680
[Abstract]
[Full Text]
-
Mizutani, K., Miki, H., He, H., Maruta, H., Takenawa, T.
(2002). Essential Role of Neural Wiskott-Aldrich Syndrome Protein in Podosome Formation and Degradation of Extracellular Matrix in src-transformed Fibroblasts. Cancer Res.
62: 669-674
[Abstract]
[Full Text]
-
Okabe, S., Urushido, T., Konno, D., Okado, H., Sobue, K.
(2001). Rapid Redistribution of the Postsynaptic Density Protein PSD-Zip45 (Homer 1c) and Its Differential Regulation by NMDA Receptors and Calcium Channels. J. Neurosci.
21: 9561-9571
[Abstract]
[Full Text]
-
Okamoto, P. M., Gamby, C., Wells, D., Fallon, J., Vallee, R. B.
(2001). Dynamin Isoform-specific Interaction with the Shank/ProSAP Scaffolding Proteins of the Postsynaptic Density and Actin Cytoskeleton. J. Biol. Chem.
276: 48458-48465
[Abstract]
[Full Text]
-
Bockers, T. M., Mameza, M. G., Kreutz, M. R., Bockmann, J., Weise, C., Buck, F., Richter, D., Gundelfinger, E. D., Kreienkamp, H.-J.
(2001). Synaptic Scaffolding Proteins in Rat Brain. ANKYRIN REPEATS OF THE MULTIDOMAIN Shank PROTEIN FAMILY INTERACT WITH THE CYTOSKELETAL PROTEIN alpha -FODRIN. J. Biol. Chem.
276: 40104-40112
[Abstract]
[Full Text]
-
Redecker, P., Gundelfinger, E. D., Boeckers, T. M.
(2001). The Cortactin-binding Postsynaptic Density Protein ProSAP1 in Non-neuronal Cells. J. Histochem. Cytochem.
49: 639-648
[Abstract]
[Full Text]
-
Kulik, G., Carson, J. P., Vomastek, T., Overman, K., Gooch, B. D., Srinivasula, S., Alnemri, E., Nunez, G., Weber, M. J.
(2001). Tumor Necrosis Factor {{alpha}} Induces BID Cleavage and Bypasses Antiapoptotic Signals in Prostate Cancer LNCaP Cells. Cancer Res.
61: 2713-2719
[Abstract]
[Full Text]
-
Weed, S. A., Karginov, A. V., Schafer, D. A., Weaver, A. M., Kinley, A. W., Cooper, J. A., Parsons, J. T.
(2000). Cortactin Localization to Sites of Actin Assembly in Lamellipodia Requires Interactions with F-Actin and the Arp2/3 Complex. JCB
151: 29-40
[Abstract]
[Full Text]
-
Zhao, Z.-s., Manser, E., Lim, L.
(2000). Interaction between PAK and Nck: a Template for Nck Targets and Role of PAK Autophosphorylation. Mol. Cell. Biol.
20: 3906-3917
[Abstract]
[Full Text]
-
Kaksonen, M, Peng, H., Rauvala, H
(2000). Association of cortactin with dynamic actin in lamellipodia and on endosomal vesicles. J. Cell Sci.
113: 4421-4426
[Abstract]
-
Sheng, M, Kim, E
(2000). The Shank family of scaffold proteins. J. Cell Sci.
113: 1851-1856
[Abstract]
-
Zitzer, H., Honck, H.-H., Bachner, D., Richter, D., Kreienkamp, H.-J.
(1999). Somatostatin Receptor Interacting Protein Defines a Novel Family of Multidomain Proteins Present in Human and Rodent Brain. J. Biol. Chem.
274: 32997-33001
[Abstract]
[Full Text]
-
Lim, S., Naisbitt, S., Yoon, J., Hwang, J.-I., Suh, P.-G., Sheng, M., Kim, E.
(1999). Characterization of the Shank Family of Synaptic Proteins. MULTIPLE GENES, ALTERNATIVE SPLICING, AND DIFFERENTIAL EXPRESSION IN BRAIN AND DEVELOPMENT. J. Biol. Chem.
274: 29510-29518
[Abstract]
[Full Text]
-
Campbell, D. H., Sutherland, R. L., Daly, R. J.
(1999). Signaling Pathways and Structural Domains Required for Phosphorylation of EMS1/Cortactin. Cancer Res.
59: 5376-5385
[Abstract]
[Full Text]
-
Gallet, C., Rosa, J.-P., Habib, A., Lebret, M., Levy-Toledano, S., Maclouf, J.
(1999). Tyrosine Phosphorylation of Cortactin Associated with Syk Accompanies Thromboxane Analogue-induced Platelet Shape Change. J. Biol. Chem.
274: 23610-23616
[Abstract]
[Full Text]
-
Boeckers, T. M., Kreutz, M. R., Winter, C., Zuschratter, W., Smalla, K.-H., Sanmarti-Vila, L., Wex, H., Langnaese, K., Bockmann, J., Garner, C. C., Gundelfinger, E. D.
(1999). Proline-Rich Synapse-Associated Protein-1/Cortactin Binding Protein 1 (ProSAP1/CortBP1) Is a PDZ-Domain Protein Highly Enriched in the Postsynaptic Density. J. Neurosci.
19: 6506-6518
[Abstract]
[Full Text]
-
Zitzer, H., Richter, D., Kreienkamp, H.-J.
(1999). Agonist-dependent Interaction of the Rat Somatostatin Receptor Subtype 2 with Cortactin-binding Protein 1. J. Biol. Chem.
274: 18153-18156
[Abstract]
[Full Text]
-
Kreienkamp, H.-J., Zitzer, H., Gundelfinger, E. D., Richter, D., Bockers, T. M.
(2000). The Calcium-independent Receptor for alpha -Latrotoxin from Human and Rodent Brains Interacts with Members of the ProSAP/SSTRIP/Shank Family of Multidomain Proteins. J. Biol. Chem.
275: 32387-32390
[Abstract]
[Full Text]
-
Iglesias, T., Cabrera-Poch, N., Mitchell, M. P., Naven, T. J. P., Rozengurt, E., Schiavo, G.
(2000). Identification and Cloning of Kidins220, a Novel Neuronal Substrate of Protein Kinase D. J. Biol. Chem.
275: 40048-40056
[Abstract]
[Full Text]
-
Tobaben, S., Sudhof, T. C., Stahl, B.
(2000). The G Protein-coupled Receptor CL1 Interacts Directly with Proteins of the Shank Family. J. Biol. Chem.
275: 36204-36210
[Abstract]
[Full Text]
-
Becamel, C., Figge, A., Poliak, S., Dumuis, A., Peles, E., Bockaert, J., Lubbert, H., Ullmer, C.
(2001). Interaction of Serotonin 5-Hydroxytryptamine Type 2C Receptors with PDZ10 of the Multi-PDZ Domain Protein MUPP1. J. Biol. Chem.
276: 12974-12982
[Abstract]
[Full Text]